Personal information

Emails & domains

Verified email domains

Websites & social links

linkedin.com/in/arailym-sarsembayeva-32680582

Keywords

Immunology, Tumor microenvironment, Transcription factor, Immunotherapy, Molecular glues

Countries

Austria, United States, Kazakhstan

Activities

Collapse all

Employment (1)

Sanford Burnham Prebys Medical Discovery Institute: La Jolla, California, US

2023-07-17 to present | Postdoctoral Associate
Employment
Source: Self-asserted source
Arailym Sarsembayeva

Education and qualifications (3)

Medical University of Graz: Graz, Steiermark, AT

2019-10-01 to 2023-05-17 | PhD in Molecular Medicine (Pharmacology)
Education
Source: Self-asserted source
Arailym Sarsembayeva

Nazarbayev University School of Medicine: Astana, KZ

2017-09-05 to 2019-06-01 | MSc In Molecular Medicine (Molecular Medicine)
Education
Source: Self-asserted source
Arailym Sarsembayeva

Dublin Institute of Technology: Dublin, Dublin, IE

2012-09-17 to 2016-10-08 | BSc in Biomedical Science (Biomedical Science)
Education
Source: Self-asserted source
Arailym Sarsembayeva

Professional activities (4)

American Association For Cancer Research: Philadelphia, Pennsylvania, US

2024-05-13 to present | Associate
Membership
Source: Self-asserted source
Arailym Sarsembayeva

Society for Immunotherapy of Cancer: Milwaukee, Wisconsin, US

2024-02-14 to present
Membership
Source: Self-asserted source
Arailym Sarsembayeva

American Association of Immunologists: Bethesda, Maryland, US

2024-01-04 to present
Membership
Source: Self-asserted source
Arailym Sarsembayeva

Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT): Vienna, AT

2020-09-20 to 2023-06-30 | Student Membership
Membership
Source: Self-asserted source
Arailym Sarsembayeva

Works (7)

Comparative Study of the Immune Microenvironment in Heterotopic Tumor Models

Cancers
2024-01-10 | Journal article | Author
DOI: 10.3390/cancers16020295
Part of ISSN: 2072-6694
Contributors: Melanie Kienzl; Kathrin Maitz; Arailym Sarsembayeva; Paulina Valadez-Cosmes; Eva Knuplez, PhD; Dusica Ristic; Karolina Herceg; Julia Kargl; Rudolf Schicho
Source: Self-asserted source
Arailym Sarsembayeva
grade
Preferred source (of 3)‎

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?

Frontiers in Oncology
2023-11-22 | Journal article
DOI: 10.3389/fonc.2023.1296906
Part of ISSN: 2234-943X
Contributors: Arailym Sarsembayeva; Rudolf Schicho
Source: Self-asserted source
Arailym Sarsembayeva

Tumor microenvironment-derived monoacylglycerol lipase provokes tumor-specific immune responses and lipid profiles

Prostaglandins, Leukotrienes and Essential Fatty Acids
2023-08 | Journal article
DOI: 10.1016/j.plefa.2023.102585
Part of ISSN: 0952-3278
Contributors: Eva Gruden; Melanie Kienzl; Carina Hasenoehrl; Arailym Sarsembayeva; Dusica Ristic; Sophie Theresa Schmid; Kathrin Maitz; Ulrike Taschler; Lisa Hahnefeld; Robert Gurke et al.
Source: Self-asserted source
Arailym Sarsembayeva

Myeloperoxidase promotes a tumorigenic microenvironment in non-small cell lung cancer

2023-01-29 | Preprint
DOI: 10.1101/2023.01.28.526014
Contributors: Paulina Valadez-Cosmes; Kathrin Maitz; Oliver Kindler; Nejra Cosic Mujkanovic; Anna Lueger; Sofia Raftopoulou; Melanie Kienzl; Zala Nikita Mihalic; Ana Santiso; Arailym Sarsembayeva et al.
Source: Self-asserted source
Arailym Sarsembayeva

Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8+ T and NK cells

Frontiers in Immunology
2023-01-09 | Journal article
DOI: 10.3389/fimmu.2022.997115
Part of ISSN: 1664-3224
Contributors: Arailym Sarsembayeva; Melanie Kienzl; Eva Gruden; Dusica Ristic; Kathrin Maitz; Paulina Valadez-Cosmes; Ana Santiso; Carina Hasenoehrl; Luka Brcic; Jörg Lindenmann et al.
Source: Self-asserted source
Arailym Sarsembayeva

Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer

OncoImmunology
2021-01-01 | Journal article
DOI: 10.1080/2162402x.2021.1965319
Part of ISSN: 2162-402X
Source: Self-asserted source
Arailym Sarsembayeva

IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils

OncoImmunology
2020-01-01 | Journal article
DOI: 10.1080/2162402x.2020.1776059
Part of ISSN: 2162-402X
Source: Self-asserted source
Arailym Sarsembayeva
How many people are using ORCID?